BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins.
BrickBio's investors include Samsung Venture Investment.
BrickBio is headquartered in Boston, United States.
BrickBio is a developer of a bioconjugation platform intended for research of site-specific modification of proteins.
BrickBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BrickBio — Funding & Investors." VCBacked, March 18, 2024, https://www.vcbacked.co/company/brickbio. Accessed August 14, 2026.
VCBacked. (2024). BrickBio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/brickbio
{{cite web |title=BrickBio — Funding & Investors |url=https://www.vcbacked.co/company/brickbio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated